UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026655
Receipt number R000030610
Scientific Title Efficacy and safety of underwater cold snare polypectomy (UCSP) for colorectal polyps
Date of disclosure of the study information 2017/03/22
Last modified on 2019/09/22 10:42:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of underwater cold snare polypectomy (UCSP) for colorectal polyps

Acronym

UCSP for colorectal polyps

Scientific Title

Efficacy and safety of underwater cold snare polypectomy (UCSP) for colorectal polyps

Scientific Title:Acronym

UCSP for colorectal polyps

Region

Japan


Condition

Condition

Colorectal polyps

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To reveal the efficacy and safety of underwater cold snare polypectomy (UCSP) for colorectal polyps

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

The morphological and phathological residual rate of adenomas 3 weeks after CSP

Key secondary outcomes

The rate of pathological complete resection (R0 resection) of UCSP, and the relationship between this and outcome of conventional cold snare polypectomy (CSP). The rate of having muscularis mucosae in specimens, morphological local recurrence at 3 weeks after UCSP, patients' characteristics (e.g. age, gender), lesions' characteristics (e.g. location, diameter, macroscopic appearance), safety (e.g. complications), and the relationship between these and outcomes of conventional CSP


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent UCSP for colorectal polyps

Key exclusion criteria

Polyposis syndromes such as familial adenomatous polyposis; inflammatory bowel disease; coagulation abnormalities; antithrombotic drug therapy; hemodialysis with a tendency to bleed; severe hepatic or renal disorders; pregnancy

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Arai

Organization

Chiba University Hospital

Division name

Gastroenterology

Zip code

260-8670

Address

Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University (K1), 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba-ken, 260-8670, Japan

TEL

+81-43-226-2083

Email

araim-cib@umin.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Maruoka

Organization

Chiba University Hospital

Division name

Gastroenterology

Zip code

260-8670

Address

1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba-ken, 260-8670, Japan

TEL

+81-43-226-2083

Homepage URL


Email

maruoka-cib@umin.ac.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Chiba University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate School of Medicine, Chiba University

Address

1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan

Tel

+81-43-222-7171

Email

igaku-rinri@office.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

千葉大学医学部附属病院(千葉県)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 22 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pubmed/31038769

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/31038769

Number of participants that the trial has enrolled

65

Results

Overall, 224 lesions in 65 patients were prospectively resected by UCSP. Pathologically, 209 lesions were adenomas (4.5+-1.5 mm). Only one pathological residual adenoma was identified, but there was no significant difference between the UCSP and CSP groups (both 1.0%). No complications were observed. R0 resection rate and rate of area containing the muscularis mucosa in the UCSP group were significantly higher than those in the CSP group (80.2% vs 32.7%, P < 0.001; 50.0% vs 35.3%, P = 0.015).

Results date posted

2019 Year 09 Month 22 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients aged over 20 years old diagnosed with colorectal adenomaswere recruited.
Exclusion criteria were as follows: (i) polyposis syndromes such as familial adenomatous polyposis; (ii) inflammatory bowel disease; (iii) coagulation abnormalities; (iv) antithrombotic drug therapy; (v) hemodialysis with a tendency to bleed; (vi) severe hepatic or renal disorders; and (vii) pregnancy.

Participant flow

The study protocol, which included earlier follow-up colonoscopy instead of routine medical examination, was clearly explained, and a written informed consent was obtained from all patients prior to their enrolment.

Adverse events

No adverse events.

Outcome measures

Primary endpoint: pathological residual tumors 3 weeks after UCSP.
Secondary outcomes: R0 resection, complete retrieval, and complication rates.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 28 Day

Date of IRB

2017 Year 03 Month 22 Day

Anticipated trial start date

2017 Year 03 Month 22 Day

Last follow-up date

2018 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Safety and efficacy of UCSP for colorectal polyps will be analyzed.


Management information

Registered date

2017 Year 03 Month 22 Day

Last modified on

2019 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030610


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name